How do I assess insulin resistance using the homeostatic model assessment (HOMA‑IR)?

How to Check HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

To assess insulin resistance using HOMA-IR, obtain fasting plasma glucose and fasting insulin levels, then calculate HOMA-IR using the formula: [fasting insulin (μU/mL) × fasting glucose (mmol/L)] ÷ 22.5 1.

Calculation Method

The HOMA-IR calculation requires two simple measurements:

• Fasting plasma glucose (in mmol/L)
• Fasting plasma insulin (in μU/mL or mU/L)

Apply the formula: HOMA-IR = [fasting insulin × fasting glucose] ÷ 22.5 1, 2

Important: The patient must be fasting (typically 8-12 hours) for accurate results. Both measurements should be obtained from the same blood draw 2, 3.

Interpretation Guidelines

While there is no universally agreed-upon threshold for defining insulin resistance using HOMA-IR 1, the following ranges provide clinical guidance:

• Normal: HOMA-IR < 2.5-2.71 1, 4
• Insulin resistance: HOMA-IR ≥ 2.5-2.71 4

Critical caveat: HOMA-IR is only valid in non-diabetic persons 1. The validity depends on the pancreas's ability to adapt insulin secretion to insulin resistance, which is impaired in overt diabetes 1.

Clinical Applications

HOMA-IR is recommended for:

• Surrogate estimation of insulin resistance in non-diabetic individuals when euglycemic clamp testing is not feasible 1
• Confirming altered insulin sensitivity in cases of diagnostic uncertainty (e.g., ultrasound-defined steatosis with normal body weight) 1
• Monitoring during follow-up to identify patients at risk of NASH or fibrosis progression 1
• Large-scale epidemiological studies where only fasting samples are available 3, 5

HOMA-IR correlates strongly with:

• Euglycemic clamp measurements (r = -0.82) 5
• Direct measures of insulin-mediated glucose disposal 5, 6

Important Limitations and Pitfalls

Do not use HOMA-IR in:

• Patients with overt diabetes mellitus 1
• Patients on medications affecting glucose/insulin (must be fasting and off interfering medications)

Technical considerations:

• Insulin assays vary widely between laboratories 1
• Proper reference values must be established for your specific laboratory 1
• The coefficient of variation is approximately 31% for insulin resistance estimates 2

Alternative Approaches

If HOMA-IR calculation is not feasible, fasting plasma insulin alone can serve as a reasonable clinical alternative 7:

• Normal: <15 mU/L
• Borderline high: 15-20 mU/L
• High: >20 mU/L

However, fasting insulin and HOMA-IR are highly correlated (r = 0.98), and HOMA-IR does not provide substantially better estimation than fasting insulin alone 6.

The gold standard remains the euglycemic insulin clamp, but this is reserved for research purposes due to its complexity (requires 3-4 hours of continuous IV insulin and glucose administration) 7.

Practical Clinical Algorithm

1. Identify at-risk patients (obesity, family history of diabetes, metabolic syndrome, PCOS, acanthosis nigricans) 7
2. Ensure patient is fasting 8-12 hours
3. Draw single blood sample for both glucose and insulin
4. Calculate HOMA-IR using the formula
5. Interpret results in context of clinical presentation and established reference values
6. Use for monitoring metabolic improvement during interventions (e.g., weight loss) 1